Tech Company Financing Transactions
Oncofactor Funding Round
OVP Venture Partners and private investors participated in a $1.7 million capital raise for Oncofactor. This VC investment round was announced on 6/30/2012.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$1,700,000
Round
Undisclosed
Investors
OVP Venture Partners (Chad Waite)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. E. 200
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Email Address
Not Recorded
Overview
Oncofactor is developing cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Sarah Warren
Browse more venture capital transactions:
Prev: 6/30/2012: Callaway Digital Arts venture capital transaction
Next: 6/30/2012: Intrapace venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs